Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis.

F Schettini,O Martínez-Sáez,C Falato,I De Santo,B Conte,I Garcia-Fructuoso, R Gomez-Bravo,E Seguí,N Chic, F Brasó-Maristany,L Paré,M Vidal, B Adamo,M Muñoz,T Pascual,E Ciruelos,C M Perou, L A Carey,A Prat

ESMO open（2023）

引用 3|浏览24

暂无评分

摘要

In HoR+ MBC, non-LumA disease is associated with poorer PFS/TTP and OS than LumA, independently of HER2, treatment and menopausal status. Future trials in HoR+ MBC should consider this clinically relevant biological classification.

查看译文

关键词

breast cancer,hormone receptors,intrinsic subtypes,metastatic,prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要